A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRAS. (Q39136326)
Jump to navigation
Jump to search
scientific article published on 10 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRAS. |
scientific article published on 10 May 2013 |
Statements
1 reference
A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRAS. (English)
1 reference
Xiang-Hua Zhang
1 reference
Ying Cheng
1 reference
Jung-Young Shin
1 reference
Jeong-Oh Kim
1 reference
Ji-Eun Oh
1 reference
Jin-Hyoung Kang
1 reference
10 May 2013
1 reference
1 reference
14
1 reference
597-605
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference